Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
accent therapeutics
aducanumab
allopregnanolone
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
biotech
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
brexanolone
c. greg guyer
cancer
cara therapeutics
clinical trials
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
drugs
esperion
europe blog main
europe top stories
financing
gilead sciences
immunomedics
incyte
What
fast
2
×
fda
new
activity
approvals
approved
bio
biogen
brexanolone
clamped
covid
delays
depression
devastating
developing
disorder
drug
economic
including
ipo
isn’t
lot
medicine
medicines
moms
oks
oric’s
partum
post
potentially
relief
roundup
showing
specifically
spread
testing
tough
work
zulresso
Language
unset
Current search:
fast
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take